Proteases and antiproteases in chronic neutrophilic lung disease - relevance to drug discovery.
about
Inhaled protein/peptide-based therapies for respiratory diseaseInhaled hypertonic saline for cystic fibrosis: Reviewing the potential evidence for modulation of neutrophil signalling and functionPotent and Selective Human Neutrophil Elastase Inhibitors with Novel Equatorial Ring Topology: in vivo Efficacy of the Polar Pyrimidopyridazine BAY-8040 in a Pulmonary Arterial Hypertension Rat ModelAerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery SystemsThe Pig: A Relevant Model for Evaluating the Neutrophil Serine Protease Activities during Acute Pseudomonas aeruginosa Lung InfectionInhibitors of human neutrophil elastase based on a highly functionalized N-amino-4-imidazolidinone scaffoldNeutrophil elastase enhances sputum solubilization in cystic fibrosis patients receiving DNase therapy.Pulmonary proteases in the cystic fibrosis lung induce interleukin 8 expression from bronchial epithelial cells via a heme/meprin/epidermal growth factor receptor/Toll-like receptor pathway.Arbutin and decrease of potentially toxic substances generated in human blood neutrophilsChanges of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients' Upper and Lower Airways after IV-Antibiotic TherapyAlterations in blood leukocytes of G551D-bearing cystic fibrosis patients undergoing treatment with ivacaftor.Respiratory protease/antiprotease balance determines susceptibility to viral infection and can be modified by nutritional antioxidantsTranscription of Interleukin-8: How Altered Regulation Can Affect Cystic Fibrosis Lung Disease.The pig as a model for investigating the role of neutrophil serine proteases in human inflammatory lung diseases.Inhibition of Neutrophil Extracellular Trap Formation after Stem Cell Transplant by Prostaglandin E2.Allergic lung inflammation promotes atherosclerosis in apolipoprotein E-deficient mice.Repurposing tromethamine as inhaled therapy to treat CF airway disease.Targeting COPD: advances on low-molecular-weight inhibitors of human neutrophil elastase.Therapeutic modulation of miRNA for the treatment of proinflammatory lung diseases.The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema.Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.HIV infection model of chronic obstructive pulmonary disease in mice.Omic approaches in environmental issues.Resolution of inflammation pathways in preeclampsia-a narrative review.Impaired response of the bronchial epithelium to inflammation characterizes severe equine asthma.Pseudomonas aeruginosa proteolytically alters the interleukin 22-dependent lung mucosal defense.A secretory leukocyte protease inhibitor variant with improved activity against lung infection.Differential In Vitro and In Vivo Toxicities of Antimicrobial Peptide Prodrugs for Potential Use in Cystic Fibrosis.Budesonide mitigates pathological changes in animal model Of COPD through reducing neutrophil elastase expressionQuantification and evaluation of the role of antielastin autoantibodies in the emphysematous lungMediators and receptors in the resolution of inflammation: drug targeting opportunities.NET balancing: a problem in inflammatory lung diseases.Impact of HIV Infection on Alpha-1 Antitrypsin in the Lung.Delivery of Alpha-1 Antitrypsin to Airways.Progranulin is a substrate for neutrophil-elastase and proteinase-3 in the airway and its concentration correlates with mediators of airway inflammation in COPD.Proresolving Actions of Synthetic and Natural Protease Inhibitors Are Mediated by Annexin A1.The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals.Effect of LysM+ macrophage depletion on lung pathology in mice with chronic bronchitis.
P2860
Q26751439-0F1E9FB8-8B47-4D4B-919B-1957629C9BB4Q26799406-D54FBFFB-4BD9-4E83-994A-0EB4198A2014Q27702090-E7AD5C91-20C6-4FA4-B2CC-B88D316C74ADQ28392004-467484FD-5440-476B-AFA8-3FBBF4244BBBQ28555083-258E7487-B9B9-48F4-822A-D3A6DB067F84Q34054400-AD51D36A-4BE5-4B3E-A5C9-4C8B4B9338CEQ34103161-F1B792F0-C0EC-4B87-9A7C-E4DBBD66D91AQ34606483-55D83450-691D-466E-9363-D6E4F6D7EF06Q35620473-B8AA1280-4D1C-4A71-A95D-D3B7D0212B06Q35817400-E69FA1E3-9BEE-4F9C-B73D-6BAE9A0B7EADQ36053155-FEF17933-C8F8-41B2-8B0D-123BEA62CE6FQ36104532-E02074CF-9A25-4E2D-9FCF-74456744959BQ36139057-DD43DB11-F529-44A8-B85B-52AA022BD752Q36382772-FC2B59E6-A34E-4D11-B88B-10783F051A55Q36516846-5BED20C0-CA17-4A15-9CF7-FDD88746700EQ36803560-330AC527-70C8-4F74-8A0A-A14F7C8AD56AQ37066264-2C00AB7A-B0FB-4C64-A1FB-CFB119DB5F19Q37890978-6653D5DD-37D9-4783-A577-578FCCA28539Q37991391-21006066-D50C-4513-A0E1-35C404E13625Q38322575-2AA9A8E8-381A-4FAF-BE19-08F4879BE12FQ38755670-11E1F786-22F6-45F2-8DEE-7FCB72B183C3Q38768300-52060678-7579-41F9-8C17-C521589DE756Q38858389-9B5E5420-162E-46C2-955A-9C9B622B25E5Q39229350-32D2A626-9DE8-43A8-912A-3C2FF5C0889DQ40060038-056EA6DD-A62E-4D00-AFFF-A783D641C0E1Q40477924-B17DEA7F-D79C-45E8-A331-18D016146817Q40996531-1AED40E1-7C1A-4324-A47C-86E244BAEB06Q41289926-8B09A5DD-639A-4097-8C14-40A5A17DBD1EQ41640230-086F2BDE-6015-44A5-B06B-A9FA47CF56A5Q41888256-FB055E83-CD96-4715-A211-43FAF4E57083Q42681904-D1C036B7-BF75-4B51-823B-3624B32DA1F1Q42947423-86440949-3C8E-489F-ACAF-D710E7359AACQ47643314-B8E83E1B-8E1B-4919-ADD1-EC89F3BE8EF1Q48093032-08D0C55F-98E1-4966-A4F7-DF4A96AC8D6CQ48145527-648B412A-B7E7-44B7-A750-C093CA442A9FQ48255748-221DF273-81B2-43A1-988A-ABAB8E9A0283Q55011363-F066C286-234C-4E6B-A8D5-65EC45A29DB4Q55338683-AD98DFC5-4485-4DF3-8104-B98A85492778
P2860
Proteases and antiproteases in chronic neutrophilic lung disease - relevance to drug discovery.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proteases and antiproteases in ...... - relevance to drug discovery.
@en
Proteases and antiproteases in ...... - relevance to drug discovery.
@nl
type
label
Proteases and antiproteases in ...... - relevance to drug discovery.
@en
Proteases and antiproteases in ...... - relevance to drug discovery.
@nl
prefLabel
Proteases and antiproteases in ...... - relevance to drug discovery.
@en
Proteases and antiproteases in ...... - relevance to drug discovery.
@nl
P2860
P1476
Proteases and antiproteases in ...... - relevance to drug discovery.
@en
P2093
Noel G McElvaney
P2860
P304
P356
10.1111/J.1476-5381.2009.00448.X
P407
P577
2009-10-01T00:00:00Z